Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Luke J Ney, Wole Akosile, Chris Davey, Louise Pitcher, Kim L Felmingham, Leah M Mayo, Matthew N Hill & Esben Strodl. (2023) Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective. Expert Review of Clinical Pharmacology 16:11, pages 1093-1108.
Read now
Read now
Manaswini Pillai, Simon Erridge, Lara Bapir, Martha Nicholas, Nishaanth Dalavaye, Carl Holvey, Ross Coomber, Daniela Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, James J Rucker & Mikael H Sodergren. (2022) Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry. Expert Review of Neurotherapeutics 22:11-12, pages 1009-1018.
Read now
Read now
C. Hindocha, J. Cousijn, M. Rall & M. A. P. Bloomfield. (2020) The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review. Journal of Dual Diagnosis 16:1, pages 120-139.
Read now
Read now
Ali A El-Solh. (2018) Management of nightmares in patients with posttraumatic stress disorder: current perspectives. Nature and Science of Sleep 10, pages 409-420.
Read now
Read now
Izaak L. Williams. (2016) The intersection of structurally traumatized communities and substance use treatment: Dominant discourses and hidden themes. Journal of Ethnicity in Substance Abuse 15:2, pages 95-126.
Read now
Read now
William D. Troutt & Matthew D. DiDonato. (2015) Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization. Journal of Psychoactive Drugs 47:4, pages 259-266.
Read now
Read now
Nicole A. Short, Kimberly A. Babson, Matthew Tyler Boden & Marcel O. Bonn-Miller. (2015) Sleep quality, problematic cannabis use and posttraumatic stress symptoms among medical cannabis users. Addiction Research & Theory 23:3, pages 246-252.
Read now
Read now
Articles from other publishers (80)
Kirsten R. Müller-Vahl. (2024) Cannabinoids in the Treatment of Selected Mental Illnesses: Practical
Approach and Overview of the Literature. Pharmacopsychiatry 57:03, pages 104-114.
Crossref
Crossref
Arisya Hanim Sharol Hisam, Nurfarhana Rasli, Nur Fatihah Abdul Razak, Ain Sofea Nabila Aidy Ajmer, Joe Dailin Daniel, Hesham Ali El Enshasy, Wen Nee Tan & Woei Yenn Tong. (2023) Potential Medical Benefits of Cannabis sativa and Its Controversies. Malaysian Journal of Medicine and Health Sciences 19:s9, pages 321-327.
Crossref
Crossref
Ying Li, Weijia Zhi, Bing Qi, Lifeng Wang & Xiangjun Hu. (2023) Update on neurobiological mechanisms of fear: illuminating the direction of mechanism exploration and treatment development of trauma and fear-related disorders. Frontiers in Behavioral Neuroscience 17.
Crossref
Crossref
E.L. Gräfe, H.M.O. Reid, I. Shkolnikov, K. Conway, A. Kit, C. Acosta & B.R. Christie. (2023) Women are taking the hit: Examining the unique consequences of cannabis use across the female lifespan. Frontiers in Neuroendocrinology 70, pages 101076.
Crossref
Crossref
Biao Gao, Yi-cui Qu, Meng-yu Cai, Yin-yin Zhang, Hong-tao Lu, Hong-xia Li, Yu-xiao Tang & Hui Shen. (2023) Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace. Journal of Integrative Medicine 21:4, pages 385-396.
Crossref
Crossref
Luke J. Ney, Kevin M. Crombie & Leah M. Mayo. 2023. Neurobiology and Physiology of the Endocannabinoid System. Neurobiology and Physiology of the Endocannabinoid System
67
79
.
Laura A. Bajor, Charmi Balsara & David N. Osser. (2022) An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update. Psychiatry Research 317, pages 114840.
Crossref
Crossref
Sanket B. Raut, Padmaja A. Marathe, Liza van Eijk, Rajaraman Eri, Manoj Ravindran, David M. Benedek, Robert J. Ursano, Juan J. Canales & Luke R. Johnson. (2022) Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Pharmacology & Therapeutics 239, pages 108195.
Crossref
Crossref
Ani Gasparyan, Daniela Navarro, Francisco Navarrete & Jorge Manzanares. (2022) Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies. Neuropharmacology 218, pages 109211.
Crossref
Crossref
Robin J Jacobs, Jessica Colon & Michael N Kane. (2022) Medical Students’ Attitudes, Knowledge, and Beliefs about Medical Cannabis: A Qualitative Descriptive Study. Cureus.
Crossref
Crossref
Michele Bedard-Gilligan, Elizabeth Lehinger, Sarah Cornell-Maier, Ash Holloway & Lori Zoellner. (2022) Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights. Current Addiction Reports 9:3, pages 203-216.
Crossref
Crossref
Yuma T. Ortiz, Lance R. McMahon & Jenny L. Wilkerson. (2022) Medicinal Cannabis and Central Nervous System Disorders. Frontiers in Pharmacology 13.
Crossref
Crossref
Marika L. Forsythe & Andrew J. Boileau. (2022) Use of cannabinoids for the treatment of patients with post-traumatic stress disorder. Journal of Basic and Clinical Physiology and Pharmacology 33:2, pages 121-132.
Crossref
Crossref
Andrzej Silczuk, Daria Smułek, Marcin Kołodziej & Julia Gujska. (2022) The Construct of Medical and Non-Medical Marijuana—Critical Review. International Journal of Environmental Research and Public Health 19:5, pages 2769.
Crossref
Crossref
Luke J. Ney, Kevin M. Crombie, Leah M. Mayo, Kim L. Felmingham, Tim Bowser & Allison Matthews. (2022) Translation of animal endocannabinoid models of PTSD mechanisms to humans: Where to next?. Neuroscience & Biobehavioral Reviews 132, pages 76-91.
Crossref
Crossref
Esezah Kakudidi, Patience Tugume, Savina Asiimwe & Godwin Anywar. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
189
210
.
Shivika Datta, Praveen C. Ramamurthy, Uttpal Anand, Simranjeet Singh, Amritpal Singh, Daljeet Singh Dhanjal, Vaishali Dhaka, Sanjay Kumar, Dhriti Kapoor, Samapika Nandy, Manoj Kumar, Eapen P. Koshy, Abhijit Dey, Jarosław Proćków & Joginder Singh. (2021) Wonder or evil?: Multifaceted health hazards and health benefits of Cannabis sativa and its phytochemicals. Saudi Journal of Biological Sciences 28:12, pages 7290-7313.
Crossref
Crossref
Danielle C. HergertCidney Robertson-BentaVeronik SicardDaniela SchwotzerKent HutchisonDan P. CoveyDavin K. QuinnJoseph R. SadekJacob McDonaldAndrew R. Mayer. (2021) Use of Medical Cannabis to Treat Traumatic Brain Injury. Journal of Neurotrauma 38:14, pages 1904-1917.
Crossref
Crossref
Luca SteardoJr.Jr., Elvira Anna Carbone, Giulia Menculini, Patrizia Moretti, Luca Steardo & Alfonso Tortorella. (2021) Endocannabinoid System as Therapeutic Target of PTSD: A Systematic Review. Life 11:3, pages 214.
Crossref
Crossref
Elizabeth L. Mazzarisi, Kay Swartzwelder & Paul Thomas Clements. (2021) Marijuana for medical use: Implications for health care providers. Journal of Interprofessional Education & Practice 22, pages 100317.
Crossref
Crossref
Rafael M. Bitencourt, Reinaldo N. Takahashi & Elisaldo A. Carlini. (2021) From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?. Frontiers in Psychiatry 12.
Crossref
Crossref
Yasir Rehman, Amreen Saini, Sarina Huang, Emma Sood, Ravneet Gill & Sezgi Yanikomeroglu. (2021) Cannabis in the management of PTSD: a systematic review. AIMS Neuroscience 8:3, pages 414-434.
Crossref
Crossref
Dorin Harpaz, Boris Veltman, Yael Sadeh, Robert S. Marks, Nirit Bernstein & Evgeni Eltzov. (2021) The effect of cannabis toxicity on a model microbiome bacterium epitomized by a panel of bioluminescent E. coli. Chemosphere 263, pages 128241.
Crossref
Crossref
Veronika Kondev, Nathan Winters & Sachin Patel. 2021. Neurobiology of Addiction and Co-Morbid Disorders. Neurobiology of Addiction and Co-Morbid Disorders
143
193
.
Kylie O'Brien & Philip BlairKylie O’Brien & Philip Blair. 2021. Medicinal Cannabis and CBD in Mental Healthcare. Medicinal Cannabis and CBD in Mental Healthcare
253
320
.
J.F. PagelJ. F. Pagel. 2021. Post-Traumatic Stress Disorder. Post-Traumatic Stress Disorder
115
124
.
Ana Maria Raymundi, Thiago R. da Silva, Jeferson M. B. Sohn, Leandro J. Bertoglio & Cristina A. Stern. (2020) Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies. BMC Psychiatry 20:1.
Crossref
Crossref
Jerome Sarris, Justin Sinclair, Diana Karamacoska, Maggie Davidson & Joseph Firth. (2020) Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry 20:1.
Crossref
Crossref
Shannon Inglet, Bradly Winter, Sarah E. Yost, Sophia Entringer, Anh Lian, Meryl Biksacky, Renee D. Pitt & Whitney Mortensen. (2020) Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. Annals of Pharmacotherapy 54:11, pages 1109-1143.
Crossref
Crossref
Anees Bahji, Arthi Chinna Meyyappan & Emily R. Hawken. (2020) Efficacy and acceptability of cannabinoids for anxiety disorders in adults: A systematic review & meta-analysis. Journal of Psychiatric Research 129, pages 257-264.
Crossref
Crossref
Yael Dagan & Joel Yager. (2020) Cannabis and Complex Posttraumatic Stress Disorder. Journal of Nervous & Mental Disease 208:8, pages 619-627.
Crossref
Crossref
Brenda Sbarski & Irit Akirav. (2020) Cannabinoids as therapeutics for PTSD. Pharmacology & Therapeutics 211, pages 107551.
Crossref
Crossref
Erwin Krediet, Debbie GA Janssen, Eibert R Heerdink, Toine CG Egberts & Eric Vermetten. (2020) Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion. European Neuropsychopharmacology 36, pages 244-254.
Crossref
Crossref
Zach Walsh. (2020) Cannabis Epistemology and the Case-Series Design: An Invited Commentary on a Case Series and a Dismissive Response. The Journal of Alternative and Complementary Medicine 26:4, pages 259-260.
Crossref
Crossref
Stephanie Lake, Thomas Kerr, Jane Buxton, Zach Walsh, Brandon DL Marshall, Evan Wood & M-J Milloy. (2019) Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of Canadians. Journal of Psychopharmacology 34:2, pages 181-188.
Crossref
Crossref
Karl Grenier, Fallon Ponnambalam, David Lee, Rebecca Lauwers & Shree Bhalerao. (2019) Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 47:1, pages 11-17.
Crossref
Crossref
Nicola Black, Emily Stockings, Gabrielle Campbell, Lucy T Tran, Dino Zagic, Wayne D Hall, Michael Farrell & Louisa Degenhardt. (2019) Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The Lancet Psychiatry 6:12, pages 995-1010.
Crossref
Crossref
Avia Saloner, Mollie M. Sacks & Nirit Bernstein. (2019) Response of Medical Cannabis (Cannabis sativa L.) Genotypes to K Supply Under Long Photoperiod. Frontiers in Plant Science 10.
Crossref
Crossref
Elena Bilevicius, Jordana L. Sommer, Gordon J. G. Asmundson & Renée El‐Gabalawy. (2019) Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. Depression and Anxiety 36:11, pages 1036-1046.
Crossref
Crossref
I. G. Silkis. (2019) The Possible Mechanism of the Appearance of Nightmares in Post-Traumatic Stress Disorder and Approaches to Their Prevention. Neurochemical Journal 13:4, pages 320-334.
Crossref
Crossref
Stefania Bonaccorso, Angelo Ricciardi, Caroline Zangani, Stefania Chiappini & Fabrizio Schifano. (2019) Cannabidiol (CBD) use in psychiatric disorders: A systematic review. NeuroToxicology 74, pages 282-298.
Crossref
Crossref
Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Papanti & John Corkery. (2019) Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina 55:9, pages 525.
Crossref
Crossref
R.A. Williams & D.W. Williams. 2019. Industrial Hemp as a Modern Commodity Crop. Industrial Hemp as a Modern Commodity Crop
73
91
.
Shera Hosseini & Mark Oremus. (2018) The Effect of Age of Initiation of Cannabis Use on Psychosis, Depression, and Anxiety among Youth under 25 Years. The Canadian Journal of Psychiatry 64:5, pages 304-312.
Crossref
Crossref
Koby Cohen, Abraham Weizman & Aviv Weinstein. (2019) Positive and Negative Effects of Cannabis and Cannabinoids on Health. Clinical Pharmacology & Therapeutics 105:5, pages 1139-1147.
Crossref
Crossref
Ralph J. Koek & Tinh N. Luong. (2019) Theranostic pharmacology in PTSD: Neurobiology and timing. Progress in Neuro-Psychopharmacology and Biological Psychiatry 90, pages 245-263.
Crossref
Crossref
Darby J. E. Lowe, Julia D. Sasiadek, Alexandria S. Coles & Tony P. George. (2018) Cannabis and mental illness: a review. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 107-120.
Crossref
Crossref
L. V. Zhyvotovska, D. I. Boiko, A. A. Sokil, O. V. Pogorilko & V. A. Voloshyn. (2019) MODERN APPROACHES TO PHARMACOTHERAPY OF POSTTRUMMATIC STRESS DISORDER. Bulletin of Problems Biology and Medicine 2:2, pages 38.
Crossref
Crossref
Sabrina F. Lisboa, C. Vila-Verde, J. Rosa, D. L. Uliana, C. A. J. Stern, L. J. Bertoglio, L. B. Resstel & F. S. Guimaraes. (2019) Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies. Psychopharmacology 236:1, pages 201-226.
Crossref
Crossref
Gregory A. Fonzo. (2018) Diminished positive affect and traumatic stress: A biobehavioral review and commentary on trauma affective neuroscience. Neurobiology of Stress 9, pages 214-230.
Crossref
Crossref
Han Zhang, Michael Xie, Stuart D. Archibald, B. Stanley Jackson & Michael K. Gupta. (2018) Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. JAMA Otolaryngology–Head & Neck Surgery 144:11, pages 1017.
Crossref
Crossref
Rafael M. Bitencourt & Reinaldo N. Takahashi. (2018) Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. Frontiers in Neuroscience 12.
Crossref
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Crossref
Ilona Shishko, Rosana Oliveira, Troy A. Moore & Kenneth Almeida. (2018) A review of medical marijuana for the treatment of posttraumatic stress disorder: Real symptom re-leaf or just high hopes?. Mental Health Clinician 8:2, pages 86-94.
Crossref
Crossref
Maria Pettinato. (2018) Cannabis medicinal: una guía para enfermeras. Nursing (Ed. española) 35:2, pages 34-39.
Crossref
Crossref
Meredith C. Meacham, Danielle E. Ramo, Alex H. Kral & Elise D. Riley. (2018) Associations between medical cannabis and other drug use among unstably housed women. International Journal of Drug Policy 52, pages 45-51.
Crossref
Crossref
Ben Sessa. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
83
104
.
Jasmine Turna, Beth Patterson & Michael Van Ameringen. (2017) Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?. Depression and Anxiety 34:11, pages 1006-1017.
Crossref
Crossref
Lesia M. Ruglass, Alina Shevorykin, Christina Brezing, Mei-Chen Hu & Denise A. Hien. (2017) Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. Journal of Substance Abuse Treatment 80, pages 45-51.
Crossref
Crossref
Maria Pettinato. (2017) Medicinal cannabis. Nursing 47:8, pages 40-46.
Crossref
Crossref
Mallory Loflin, Mitch Earleywine & Marcel Bonn-Miller. (2017) Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD. Addictive Behaviors 68, pages 18-23.
Crossref
Crossref
Maria M. Steenkamp, Esther M. Blessing, Isaac R. Galatzer-Levy, Laura C. Hollahan & William T. Anderson. (2017) Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Depression and Anxiety 34:3, pages 207-216.
Crossref
Crossref
Zach Walsh, Raul Gonzalez, Kim Crosby, Michelle S. Thiessen, Chris Carroll & Marcel O. Bonn-Miller. (2017) Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review 51, pages 15-29.
Crossref
Crossref
Ben Sessa. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
29
.
Benjamin Kelmendi, Thomas G. Adams, Stephanie Yarnell, Steven Southwick, Chadi G. Abdallah & John H. Krystal. (2016) PTSD: from neurobiology to pharmacological treatments. European Journal of Psychotraumatology 7:1.
Crossref
Crossref
Mariana P. Halah, Michelle P. Zochniak, Mera S. Barr & Tony P. George. (2016) Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment. Current Addiction Reports 3:4, pages 450-462.
Crossref
Crossref
Katherine Mills, Emma Barrett, Sabine Merz, Julia Rosenfeld, Philippa Ewer, Claudia Sannibale, Amanda Baker, Sally Hopwood, Sudie Back, Kathleen Brady & Maree Teesson. (2016) Integrated Exposure-Based Therapy for Co-Occurring Post Traumatic Stress Disorder (PTSD) and Substance Dependence: Predictors of Change in PTSD Symptom Severity. Journal of Clinical Medicine 5:11, pages 101.
Crossref
Crossref
Ernest Small. 2016. Cannabis. Cannabis
229
252
.
Andrea Berardi, Gustav Schelling & Patrizia Campolongo. (2016) The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. Pharmacological Research 111, pages 668-678.
Crossref
Crossref
Margaret Haney & A Eden Evins. (2015) Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed. Neuropsychopharmacology 41:2, pages 393-401.
Crossref
Crossref
Nancy G. Forger, J. Alex Strahan & Alexandra Castillo-Ruiz. (2016) Cellular and molecular mechanisms of sexual differentiation in the mammalian nervous system. Frontiers in Neuroendocrinology 40, pages 67-86.
Crossref
Crossref
Matthew J. Johnson, John D. Pierce, Shahrzad Mavandadi, Johanna Klaus, Diana Defelice, Erin Ingram & David W. Oslin. (2016) Mental health symptom severity in cannabis using and non-using Veterans with probable PTSD. Journal of Affective Disorders 190, pages 439-442.
Crossref
Crossref
Ben Sessa. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
26
.
Esther M. Blessing, Maria M. Steenkamp, Jorge Manzanares & Charles R. Marmar. (2015) Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics 12:4, pages 825-836.
Crossref
Crossref
Kevin Betthauser, Jeffrey Pilz & Laura E. Vollmer. (2015) Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. American Journal of Health-System Pharmacy 72:15, pages 1279-1284.
Crossref
Crossref
Eric P. Baron. (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache: The Journal of Head and Face Pain 55:6, pages 885-916.
Crossref
Crossref
Eva Hoch, Udo Bonnet, Rainer Thomasius, Florian Ganzer, Ursula Havemann-Reinecke & Ulrich W. Preuss. (2015) Risks Associated With the Non-Medicinal Use of Cannabis. Deutsches Ärzteblatt international.
Crossref
Crossref
Santiago Papini, Gregory M. Sullivan, Denise A. Hien, Erel Shvil & Yuval Neria. (2015) Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: A critical review of preclinical research. Biological Psychology 104, pages 8-18.
Crossref
Crossref
Adam Michael Stewart, Ester Yang, Michael Nguyen & Allan V. Kalueff. (2014) Developing zebrafish models relevant to PTSD and other trauma- and stressor-related disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 55, pages 67-79.
Crossref
Crossref
Pablo Roitman, Raphael Mechoulam, Rena Cooper-Kazaz & Arieh Shalev. (2014) Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder. Clinical Drug Investigation 34:8, pages 587-591.
Crossref
Crossref